Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Acurx Pharmaceuticals to discuss second quarter 2025 Financial results Conference Call.
Acurx Pharmaceuticals Inc. (ACXP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 53,927 | $550,918 | 0.01% | |
| 2. | Renaissance Technologies Jim Simons | 4,389.05 | $44,839 | +231% | 0% |
| 3. | Sabby Capital Hal Mintz | 4,094.6 | $41,830 | -96% | 0.08% |
| 4. | 3,140 | $32,078 | 0% | ||
| 5. | 2,845 | $29,065 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.02 | 24,631 | $25,000.47 | 27,708 | 2025-01-06 | Filing | |
| $1.02 | 24,631 | $25,000.47 | 137,183 | 2025-01-06 | Filing | |
| $1.02 | 49,261 | $49,999.92 | 1,097,458 | 2025-01-06 | Filing | |
| $1.02 | 9,852 | $9,999.78 | 22,352 | 2025-01-06 | Filing | |
| $1.02 | 49,261 | $49,999.92 | 1,010,196 | 2025-01-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,838.8 | $151,588 | 0.09% | |
| 2. | 7,320.2 | $74,791 | 0% | |
| 3. | 7,276.85 | $74,369 | 0% | |
| 4. | 5,310.05 | $54,247 | 0% | |
| 5. | 3,487.25 | $35,625 | 0% |
News See All
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2025 Earnings Call Transcript
Operator: Greetings and welcome to the Acurx Pharmaceuticals First Quarter 2025 Financial Results and Business Update. At this time, all participants are in a listen-only mode.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter and Full Year 2024 Financial Results and Business Update. At this time, all participants are in a listen-only mode.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Acurx Pharmaceuticals, Inc. Third Quarter 2024 Results and Business Update Conference Call.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q2 2024 Earnings Call Transcript
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q2 2024 Earnings Call Transcript August 9, 2024Acurx Pharmaceuticals, Inc. misses on earnings expectations.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Acurx Pharmaceuticals First Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Acurx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Earnings Results and Business Update Call.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
12 Best Day Trading Stocks To Buy
Over the past few years, the rise of a new generation of stock traders that like to engage in risky bets, coupled with the advent of stock trading mobile applications, has given increased popularity to...
Hedge Fund Resource Center Billionaire Hedge Funds
